Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a controlled study to determine the effectiveness and safety of MB12066 in the treatment of adult patients with Nonalcoholic Fatty Liver Disease(NAFLD) except cirrhosis.
Epistemonikos ID: 659c15d8c6ed9bf04f29324519021a8995bf2387
First added on: May 11, 2024